Published in Health Business Week, January 19th, 2007
Patient safety is Bayer's primary concern and we believe updating the label and informing healthcare professionals about the appropriate use of Trasylol is very important.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.